9 months ago
OBSVF
AnalystsRaghuram SelvarajuRaghuram Selvaraju's Stock Forecasts
AnalystsRaghuram Selvaraju
Analyst Ranking
Bottom 1%
#4198 out of 4227 analysts
Average Return
-4.27%
Win Rate
36%139 out of 383
Risk vs Reward
Poor
Good
Raghuram Selvaraju's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cormedix IncCRMD | +677.78% | $0.90 | $7.00 | 2018-05-23 - 2019-05-23 | Buy |
Anavex Life Sciences CorpAVXL | +547.79% | $2.49 | $16.13 | 2020-03-16 - 2021-03-16 | Buy |
Provention Bio IncPRVB | +452.19% | $4.33 | $23.91 | 2022-07-11 - 2023-03-15 | Buy |
Biolife Solutions IncBLFS | +380.32% | $8.74 | $41.98 | 2020-03-23 - 2021-03-23 | Buy |
Sorrento Therapeutics IncSRNEQ | +332.43% | $1.85 | $8.00 | 2020-03-30 - 2021-03-30 | Buy |
Raghuram Selvaraju Analyst Color
Get additional color on Raghuram Selvaraju's coverage of popular stocks
Raghuram Selvaraju's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Entrada Therapeutics IncTRDA | 2 | Buy | $25.00 | +112.59% | Reiterates | 4 days ago |
Galecto IncGLTO | 2 | Buy | $12.00 | +435.71% | Reiterates | 4 days ago |
Cocrystal Pharma IncCOCP | 4 | Buy | $12.00 | +430.97% | Maintains | 4 days ago |
Genmab AGMAB | 10 | Buy | $51.00 | +25.55% | Maintains | 6 days ago |
Bioxcel Therapeutics IncBTAI | 18 | Buy | $66.00 | +249.76% | Reiterates | 11 days ago |
Karuna Therapeutics IncKRTX | 8 | Buy | $300.00 | +36.26% | Reiterates | 12 days ago |
Gain Therapeutics IncGANX | 4 | Buy | $10.00 | +117.86% | Reiterates | 13 days ago |
Moonlake ImmunotherapeuticsMLTX | 8 | Buy | $37.00 | +35.43% | Reiterates | 13 days ago |
Urogen Pharma LtdURGN | 9 | Buy | $23.00 | +130.69% | Reiterates | 13 days ago |
Equillium IncEQ | 4 | Buy | $5.50 | +756.70% | Reiterates | 13 days ago |
Regulus Therapeutics IncRGLS | 2 | Buy | $9.00 | +571.64% | Reiterates | 13 days ago |
Kezar Life Sciences IncKZR | 5 | Buy | $19.00 | +564.34% | Maintains | 16 days ago |
Rapt Therapeutics IncRAPT | 11 | Buy | $41.00 | +101.47% | Maintains | 16 days ago |
Aeterna Zentaris IncAEZS | 7 | Buy | $28.00 | +896.44% | Reiterates | 16 days ago |
Axsome Therapeutics IncAXSM | 10 | Buy | $200.00 | +186.53% | Reiterates | 17 days ago |
Cardiff Oncology IncCRDF | 8 | Buy | $14.00 | +743.37% | Maintains | 19 days ago |
Microbot Medical IncMBOT | 1 | Buy | $8.00 | +279.15% | Maintains | 19 days ago |
Selecta Biosciences IncSELB | 4 | Buy | $5.00 | +376.19% | Reiterates | 20 days ago |
Reviva Pharmaceuticals Holdings IncRVPH | 4 | Buy | $10.00 | +89.39% | Reiterates | 20 days ago |
Entera Bio LtdENTX | 4 | Buy | $10.00 | +1,172.26% | Reiterates | 20 days ago |
Fate Therapeutics IncFATE | 1 | Hold | $7.00 | +36.45% | Reiterates | 23 days ago |
Indaptus Therapeutics IncINDP | 5 | Buy | $12.00 | +650.00% | Reiterates | 24 days ago |
Rockwell Medical IncRMTI | 9 | Buy | $7.00 | +192.89% | Reiterates | a month ago |
Anavex Life Sciences CorpAVXL | 9 | Buy | $54.00 | +479.40% | Reiterates | a month ago |
Enlivex Therapeutics LtdENLV | 5 | Buy | $15.00 | +481.40% | Reiterates | a month ago |
Annovis Bio IncANVS | 3 | Buy | $40.00 | +198.73% | Reiterates | a month ago |
Brainsway LtdBWAY | 7 | Buy | $12.00 | +689.47% | Maintains | a month ago |
Sol Gel Technologies LtdSLGL | 9 | Buy | $19.00 | +427.78% | Reiterates | 2 months ago |
Spero Therapeutics IncSPRO | 6 | Buy | $6.00 | +238.98% | Reiterates | 2 months ago |
Verona Pharma PLCVRNA | 5 | Buy | $32.00 | +49.60% | Reiterates | 2 months ago |
Fennec Pharmaceuticals IncFENC | 5 | Buy | $18.00 | +147.59% | Reiterates | 2 months ago |
Adma Biologics IncADMA | 7 | Buy | $4.50 | +10.29% | Reiterates | 2 months ago |
Spruce Biosciences IncSPRB | 3 | Buy | $10.00 | +311.52% | Maintains | 2 months ago |
Galera Therapeutics IncGRTX | 4 | Buy | $6.00 | +97.37% | Maintains | 2 months ago |
Eton Pharmaceuticals IncETON | 6 | Buy | $10.00 | +159.27% | Reiterates | 2 months ago |
Provention Bio IncPRVB | 6 | Hold | $25.00 | +0.08% | Downgrades | 2 months ago |
Oncternal Therapeutics IncONCT | 3 | Buy | $7.00 | +2,225.58% | Reiterates | 2 months ago |
Chromadex CorpCDXC | 8 | Buy | $5.00 | +249.65% | Maintains | 3 months ago |
Aclaris Therapeutics IncACRS | 4 | Buy | $43.00 | +418.70% | Maintains | 3 months ago |
Balchem CorpBCPC | 7 | Buy | $140.00 | +14.28% | Maintains | 3 months ago |
Talaris Therapeutics IncTALS | 3 | Buy | $12.00 | +331.65% | Reiterates | 4 months ago |
Taro Pharmaceutical Industries LtdTARO | 7 | Buy | $35.00 | +19.09% | Maintains | 4 months ago |
Cingulate IncCING | 1 | Buy | $5.50 | +516.59% | Initiates Coverage On | 4 months ago |
Timber Pharmaceuticals IncTMBR | 4 | Buy | $50.00 | +3,631.34% | Maintains | 7 months ago |
Aquestive Therapeutics IncAQST | 4 | Buy | $5.00 | +123.21% | Maintains | 9 months ago |
Obseva SaOBSVF | 6 | Hold | N/A | N/A | Downgrades | 9 months ago |
Arcadia Biosciences IncRKDA | 7 | Buy | $120.00 | +2,730.19% | Maintains | 9 months ago |
Aptinyx IncAPTX | 2 | Buy | $1.00 | +1,539.34% | Maintains | 9 months ago |
Fresh Tracks Therapeutics IncFRTX | 2 | Buy | $4.50 | +650.00% | Maintains | 9 months ago |
Ayala Pharmaceuticals IncAYLA | 2 | Buy | $12.00 | +2,280.95% | Maintains | 9 months ago |
Evofem Biosciences IncEVFM | 8 | Buy | $4.00 | +736.82% | Maintains | 9 months ago |
Angion Biomedica CorpANGN | 5 | Hold | N/A | N/A | Downgrades | 10 months ago |
Addex Therapeutics LtdADXN | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Tyra Biosciences IncTYRA | 1 | Buy | $12.00 | -13.98% | Initiates Coverage On | a year ago |
Neubase Therapeutics IncNBSE | 3 | Buy | $10.00 | +5,549.72% | Maintains | a year ago |
Vaccitech PLCVACC | 1 | Buy | $22.00 | N/A | Maintains | a year ago |
Sorrento Therapeutics IncSRNEQ | 4 | Buy | $20.00 | N/A | Maintains | a year ago |
Bridgebio Pharma IncBBIO | 3 | Buy | $24.00 | N/A | Maintains | a year ago |
Oramed Pharmaceuticals IncORMP | 2 | Buy | $32.00 | N/A | Maintains | a year ago |
Inmed Pharmaceuticals IncINM | 1 | Buy | $150.00 | N/A | Initiates Coverage On | a year ago |
Abeona Therapeutics IncABEO | 5 | Buy | $100.00 | N/A | Maintains | a year ago |
Gri Bio IncGRI | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Omeros CorpOMER | 4 | Buy | $12.00 | N/A | Maintains | 2 years ago |
Landos Biopharma IncLABP | 1 | Buy | $500.00 | N/A | Initiates Coverage On | 2 years ago |
Synlogic IncSYBX | 2 | Buy | $7.00 | N/A | Maintains | 2 years ago |
Adamas Pharmaceuticals IncADMS | 2 | Hold | $9.10 | N/A | Downgrades | 2 years ago |
Redhill Biopharma LtdRDHL | 2 | Buy | $840.00 | N/A | Maintains | 2 years ago |
Itamar Medical LtdITMR | 3 | Hold | $31.00 | N/A | Downgrades | 2 years ago |
Immunic IncIMUX | 3 | Buy | $25.00 | N/A | Maintains | 2 years ago |
Acorda Therapeutics IncACOR | 4 | Buy | $10.00 | N/A | Upgrades | 2 years ago |
Exicure IncXCUR | 2 | Buy | $180.00 | N/A | Maintains | 2 years ago |
Repligen CorpRGEN | 5 | Buy | $240.00 | N/A | Maintains | 2 years ago |
Protalix Biotherapeutics IncPLX | 3 | Buy | $7.00 | N/A | Maintains | 2 years ago |
Bausch Health Companies IncBHC | 4 | Buy | $55.00 | N/A | Maintains | 2 years ago |
Tff Pharmaceuticals IncTFFP | 2 | Buy | $37.00 | N/A | Maintains | 2 years ago |
Viela Bio IncVIE | 2 | Hold | $53.00 | N/A | Downgrades | 2 years ago |
Neurobo Pharmaceuticals IncNRBO | 2 | Buy | $480.00 | N/A | Maintains | 2 years ago |
Zosano Pharma CorpZSANQ | 2 | Buy | $2.50 | N/A | Maintains | 3 years ago |
Caredx IncCDNA | 3 | Buy | $40.00 | N/A | Maintains | 3 years ago |
Meridian Bioscience IncVIVO | 1 | Buy | $34.00 | N/A | Initiates Coverage On | 3 years ago |
Applied Dna Sciences IncAPDN | 2 | Buy | $22.00 | N/A | Maintains | 3 years ago |
Biospecifics Technologies CorpBSTC | 2 | Buy | $100.00 | N/A | Maintains | 3 years ago |
Cytodyn IncCYDY | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Replimune Group IncREPL | 1 | Hold | $25.00 | N/A | Downgrades | 3 years ago |
Igm Biosciences IncIGMS | 1 | Buy | $88.00 | N/A | Initiates Coverage On | 3 years ago |
Evoke Pharma IncEVOK | 2 | Buy | $120.00 | N/A | Upgrades | 3 years ago |
Biolife Solutions IncBLFS | 1 | Buy | $17.00 | N/A | Maintains | 3 years ago |
Springworks Therapeutics IncSWTX | 1 | Buy | $60.00 | N/A | Upgrades | 3 years ago |
Stemline Therapeutics IncSTML | 1 | Buy | $18.00 | N/A | Maintains | 3 years ago |
Kala Pharmaceuticals IncKALA | 3 | Buy | $600.00 | N/A | Reiterates | 4 years ago |
First Wave Biopharma IncFWBI | 2 | Buy | $7.00 | N/A | Maintains | 4 years ago |
Celcuity IncCELC | 1 | Buy | $36.00 | N/A | Initiates Coverage On | 5 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $32.00 | N/A | Initiates Coverage On | 5 years ago |
Cormedix IncCRMD | 2 | Buy | $10.00 | N/A | Maintains | 5 years ago |
Ladrx CorpLADX | 1 | Buy | $4.50 | N/A | Maintains | 5 years ago |
Check Cap LtdCHEK | 1 | Buy | $280.00 | N/A | Maintains | 5 years ago |
Oncosec Medical IncONCS | 2 | Buy | $880.00 | N/A | Maintains | 5 years ago |
T2 Biosystems IncTTOO | 2 | Buy | $425.00 | N/A | Maintains | 5 years ago |
Lisata Therapeutics IncLSTA | 1 | Buy | $12.00 | N/A | Maintains | 5 years ago |
Durect CorpDRRX | 2 | Buy | $35.00 | N/A | Upgrades | 5 years ago |
Dentsply Sirona IncXRAY | 3 | Hold | $63.00 | N/A | Maintains | 5 years ago |
Aethlon Medical IncAEMD | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 6 years ago |
Kiora Pharmaceuticals IncKPRX | 1 | Buy | $5.00 | N/A | Maintains | 6 years ago |
Bio Path Holdings IncBPTH | 1 | Buy | $300.00 | N/A | Maintains | 6 years ago |
Immuron LtdIMRN | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 6 years ago |
Foamix Pharmaceuticals LtdFOMX | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 6 years ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 6 years ago |
Alimera Sciences IncALIM | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.